CDKN2A and neoplasm: Our data support the view that treatment approaches based on inducing p16ink4a and related G0/G1 growth arrest, in tumor cells that lack p16ink4a, can induce tumor stabilization, but may also enhance pro-survival signals and thereby confer resistance to chemotherapy treatments.